| INTRODUCTION
Dendritic cells (DCs) are antigen-presenting cells that capture, process, and present antigens to lymphocytes to initiate and regulate the adaptive immune response. 1 Based on function and phenotype, DCs can be divided into plasmacytoid dendritic cells (pDCs) and conventional dendritic cells (cDCs). Langerhans cells are another member of the DC family found in oral mucosal epithelium and the skin epidermis. 2 DCs play a key role in immune defense; when immune homeostasis mediated by DCs is disrupted, inflammatory destruction may occur. 3 There is ample evidence that DCs are activated in experimental periodontitis in animals and in humans with periodontitis. Interestingly, DCs have the potential to play protective or destructive roles or both. Due to the limited number of studies examining cause and effect relationships, this issue is not entirely clear. However, there are reports in which deletion of Langerhans cells or reduced DC function through lineage-specific FOXO1 deletion have been shown to increase susceptibility to periodontitis, [4] [5] [6] suggesting that in animal models DCs have an overall effect in the periodontium that is protective.
| DCs and subsets
Dendritic cells are derived from CD34 + hematopoietic stem cells in the bone marrow. 7 These progenitor cells initially differentiate to immature DCs, which have high endocytic activity and low T-cell activation potential. 8, 9 Immature DCs express various pattern recognition receptors that constantly sample the surrounding environment for pathogens such as viruses and bacteria. 10 Maturation of DCs is induced by captured microbes or their components, 11, 12 inflammatory cytokines and ligation of select cell surface receptors. [11] [12] [13] Once DCs take up antigen they become activated into mature DCs and present pathogen fragments at their cell surface using MHC molecules. DCs 
R E V I E W A R T I C L E
The function of dendritic cells in modulating the host response 33 and a proliferation-inducing ligand (APRIL). 34 They also promote B-cell differentiation to plasma cells both via the secretion of IFN-α and IL-6 35 and via direct cell-cell contact. 36 DCs promote Th17 cell differentiation through secretion of the cytokines transforming growth factor-β (TGF-β), IL-23, and IL-1β. 37 DCs can induce the differentiation of Treg cells via TGF-β and IL-10. 38 For example, DCs in- tion. 43 IFN-γ is the signature cytokine of Th1-type responses 44 associated with activating phagocytosis and the production of inflammatory cytokines and chemokines. 45 Th1 responses have also been linked to increased receptor activator of nuclear factor-κB ligand (RANKL) expression, 46 promotion of osteoclast formation and alveolar bone loss in vivo. 47 Moreover, IFN-γ is present at high levels in periodontal lesions and is associated with progressive lesions or more severe periodontal disease. 48 Oral infection with P. gingivalis in mice increases the number of cDCs, which is positively correlated with the generation of a Th17 response. 47, 49 Oral infection with P. gingivalis and Fusobacterium nucleatum stimulates the migration of cDCs to the lymph nodes and gingiva and is associated with increased IL-17 levels, as well as other pro-inflammatory factors such as TNF, IL-6, and IL-1β, which contribute to alveolar bone loss. 4, 50 In humans, IL-17 levels are correlated with more mature cDCs and increased periodontal bone loss. 41 
| DCs protective role in periodontal disease through Treg cell response
Regulatory T cells limit excessive inflammation and bone loss. 54 In active periodontal lesions, Treg-related cytokine levels are inversely related to RANKL levels. 69, 70 Inhibition of Treg function leads to higher levels of IFN-γ, TNF-α, and RANKL and more alveolar bone loss. 71 Oral
DCs have the capacity to induce a Treg response through the secretion of IL-10 and TGF-β. 72 The importance of IL-10 is illustrated by the finding that in IL-10 knockout mice, susceptibility to P. gingivalis-induced alveolar bone loss is greatly increased. 73 Moreover, after periodontal treatment, inflammation is reduced and IL-10 expression is increased. 74 (Figure 1 ). Meanwhile IL-10 and TGF-β from DCs can potentially have the opposite effect, reducing inflammation. 81 
| DCs may affect periodontal disease through enhancement or attenuation of the innate immune response

| The role of Langerhans cells in periodontal disease
Langerhans cells, a subset of DCs, have been linked to periodontal disease. There is a positive correlation between the number of Langerhans cells in the gingival epithelium of patients with chronic periodontitis vs healthy persons 82, 83 and increased numbers in individuals with chronic gingivitis compared with non-inflamed gingiva. 84 There is increased migration of Langerhans cells to the gingival epithelium in response to the accumulation of bacterial plaque 85 and a decrease following periodontal treatment. 86 In one of the few cause and effect studies, In humans, cDCs are contributors to inflammatory bone destruction.
Synovial fluid from arthritic patients increases the differentiation of osteoclasts from immature but committed cDCs. 90 Moreover, the presence of Th17 cells is associated with the emergence of cDC-derived osteoclasts. 92 In myeloproliferative diseases, the participation of DC to osteoclast formation has also been suggested. Langerhans cell histiocytosis is a rare disease caused by the clonal accumulation of dendritic Langerhans cells. It is frequently associated with osteolytic lesion and multinucleated giant cells expressing osteoclast markers (TRAP, cathepsin K, MMP9).
Bone loss in this disease can be accounted for by the transdifferentiation of cDCs to functional osteoclasts both in vivo and in vitro. 94 
| PHOSPHOINOSITIDE 3 KINASE/ AKT-FOXO1 SIGNALING PATHWAY IN DCS
| FOXO1 promotes DC activity and Akt enhances DC survival and proliferation
FOXO1, a member of the forkhead transcription factor family, plays an important role in the regulation of many cellular and biological processes that include protection against oxidative stress, apoptosis, and progression through the cell cycle. 95 [107] [108] [109] In plasmacytoid DCs, the PI3K-Akt pathway is an important regulator of type I IFN production via activation of the IFN-regulatory factor 7.
110,111
| PI3K/Akt-FOXO1 signaling pathway in DCs in periodontal disease
It has been shown that FOXO1 activation promotes the expression of inflammatory cytokines in a number of cell types including DCs, 4 macrophages, 112 and epithelial cells. 113 This result suggests that deletion of FOXO1 in DCs could reduce periodontal bone loss through reduced inflammatory cytokine expression. However, experimental evidence is the opposite; deletion of FOXO1 in DCs increases susceptibility to periodontitis.
Porphyromonas gingivalis increases FOXO1 gene expression in cDCs through TLR signaling. 99, 114 Oral infection stimulates recruitment of cDCs to oral mucosal epithelium and connective tissue. 4 Deletion of FOXO1 specifically in cDCs blocks enhanced recruitment of cDCs and increases susceptibility to periodontitis. 4 Oral infection stimulates migration of cDCs to the cervical lymph nodes, the formation of plasma cells and bacteria-specific antibody production. 115 However, the direct linkage to the Akt-FOXO1 axis in DCs was not demonstrated due to the global nature of the gene deletion and because TAK1 has other substrates such as nuclear factor-κB that may also be responsible for the effect.
In another study, the compound piperlongumine was shown to inhibit DC maturation and reduce the symptoms of rheumatoid arthritis.
Although these changes were associated with an inhibition of the Akt pathway in DCs, a cause and effect relationship was not established because piperlongumine affects several other pathways including nuclear factor-κB. 
